MEDS Earnings

Quarterly EPS
$-22.75
Q3 2022
$-0.04
Q4 2022
$-25.25
Q1 2023
$-72.50
Q2 2023
$-114.25
Q3 2023
$-12.50
Q4 2023
$512.25
Q1 2024
$-32.50
Q2 2024
Latest Revenue18.7K
Latest Net Income-1833902
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2024-$32.5018.7K-1833902-94.9%+55.2%
Q1 2024$512.25021.2M-100.0%+2,128.7%
Q4 2023-$12.50128.7K-11665629-94.3%-31,150.0%
Q3 2023-$114.25392.3K-3525114-80.9%-402.2%
Q2 2023-$72.50366.5K-1974878-88.8%-45.7%
Q1 2023-$25.25493.3K-677953-84.8%-741.7%
Q4 2022-$0.042.3M-1303029-5.5%+60.0%
Q3 2022-$22.752.1M-528742-19.4%-468.8%
Q2 2022-$49.753.3M-1112261——
Q1 2022-$3.003.2M-965836——
Q4 2021-$0.102.4M-784340——
Q3 2021-$4.002.6M-1301748——
DataMeds AI (MEDS) — Earnings